These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 18369969)
1. Drug delivery in cancer using liposomes. Dass CR Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969 [TBL] [Abstract][Full Text] [Related]
2. Physical mechanisms and methods employed in drug delivery to tumors. Besić E Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107 [TBL] [Abstract][Full Text] [Related]
3. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Malam Y; Loizidou M; Seifalian AM Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467 [TBL] [Abstract][Full Text] [Related]
6. Passive and active drug targeting: drug delivery to tumors as an example. Torchilin VP Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525 [TBL] [Abstract][Full Text] [Related]
7. [Application of novel drug delivery system, fusogenic liposome, for cancer therapy]. Kunisawa J; Mayumi T Gan To Kagaku Ryoho; 2001 May; 28(5):577-83. PubMed ID: 11383204 [TBL] [Abstract][Full Text] [Related]
8. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery. Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868 [TBL] [Abstract][Full Text] [Related]
9. Sterically stabilized liposomes in cancer therapy and gene delivery. Lasic DD; Vallner JJ; Working PK Curr Opin Mol Ther; 1999 Apr; 1(2):177-85. PubMed ID: 11715941 [TBL] [Abstract][Full Text] [Related]
10. pH-sensitive liposomes--principle and application in cancer therapy. Karanth H; Murthy RS J Pharm Pharmacol; 2007 Apr; 59(4):469-83. PubMed ID: 17430630 [TBL] [Abstract][Full Text] [Related]
11. Liposome-based drug delivery systems. Langner M; Kral TE Pol J Pharmacol; 1999; 51(3):211-22. PubMed ID: 10600035 [TBL] [Abstract][Full Text] [Related]
12. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool. Kaneda Y Expert Opin Drug Deliv; 2010 Sep; 7(9):1079-93. PubMed ID: 20716020 [TBL] [Abstract][Full Text] [Related]
13. Nano- or submicron-sized liposomes as carriers for drug delivery. Fang JY Chang Gung Med J; 2006; 29(4):358-62. PubMed ID: 17051832 [TBL] [Abstract][Full Text] [Related]
15. Characterization of cationic liposomes having IL-2 expressed on their external surface, and their affinity to cervical cancer cells expressing the IL-2 receptor. Corona-Ortega T; Rangel-Corona R; Hernández-Jiménez M; Baeza I; Ibáñez M; Weiss-Steider B J Drug Target; 2009 Aug; 17(7):496-501. PubMed ID: 19514860 [TBL] [Abstract][Full Text] [Related]